Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2014

Conditions
Allergic RhinitisAsthma
Interventions
DRUG

leukotriene D4

Nasal challenge using 16% ethanol diluent, the concentration of which corresponded to the highest concentration of LTD4, was undertaken for exclusion of subjects hypersensitive to ethanol or saline. The LTD4 challenge could be initiated provided that NAR increase was \<30%. Ranges of 4 to 16 mcg.mL-1 LTD4 diluents were applied for a double-fold increment approach at intervals of 6 minutes.

DRUG

histamine

Nasal challenge using 0.9% saline, was undertaken for exclusion of subjects hypersensitive to saline. The histamine nasal challenge could be initiated provided that NAR increase was \<30%. Ranges of 0.4 to 3.2 mg.mL-1 histamine diluents were applied for a double-fold increment approach at intervals of 3 minutes.

Trial Locations (1)

510120

Guangzhou institute of respiratory disease, Guangzhou

All Listed Sponsors
lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT01963741 - Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis | Biotech Hunter | Biotech Hunter